Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 pat
![Study of biochemical test and some tumor marker (CEA, α-Fetoprotein, CA 19-9) in women which infected by papillomavirus - ScienceDirect Study of biochemical test and some tumor marker (CEA, α-Fetoprotein, CA 19-9) in women which infected by papillomavirus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214785321043194-gr1.jpg)
Study of biochemical test and some tumor marker (CEA, α-Fetoprotein, CA 19-9) in women which infected by papillomavirus - ScienceDirect
![Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c1eae23e45b321ff3fb5ebd61780eb875db8cd89/5-Table1-1.png)
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![IJMS | Free Full-Text | The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer IJMS | Free Full-Text | The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer](https://www.mdpi.com/ijms/ijms-22-06183/article_deploy/html/images/ijms-22-06183-g001.png)
IJMS | Free Full-Text | The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer
![Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - ScienceDirect Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500218303775-pl1.jpg)